Clinical trial for Glaucoma
Official title Modified Trabeculectomy After Failure of Combined Phaco With GATT
ClinicalTrials.gov ID: NCT07455786
What this study is testing
- What it's testing
- The study aims to find out how effective these modified trabeculectomy techniques are after earlier surgeries did not control glaucoma.
- What's involved
- Participants will have one of several modified eye surgeries, deep non‑penetrating sclerectomy, viscocanalostomy, or small‑incision trabeculectomy, that avoid Tenon’s capsule.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 to 70
You may be able to join if
- All patients had combined phaco surgery with GATT.
- All patients had phaco with goinopuncture.
You likely can't join if
- Healthy patient.
- No history of phaco surgery with GATT or goinopuncture.
The study team makes the final eligibility decision.
Where it is enrolling
- Asyut, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Asyut, Egypt. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.